Abstracts tagged "MRI and osteoarthritis"

Abstract Number: 868 • 2018 ACR/ARHP Annual Meeting
International Multi-Reader Validation of the Outcome Measures in Rheumatology Hip MRI Scoring System (OMERACT HIMRISS) for Bone Marrow Lesions in Osteoarthritis
Jacob L. Jaremko¹, Robert G. Lambert², Susanne J Pedersen³, Ulrich Weber⁴, Duncan Lindsay⁵, Zeid Al-Ani⁵, Marcus Pianta⁶, Stephanie Wichuk⁷, Kieran Steer⁸, Joel Paschke⁹ and Walter P. Maksymowych¹⁰, ¹Radiology, University of Alberta, Edmonton, Canada, Edmonton, AB, Canada, ²Radiology, Radiology, University of Alberta, Edmonton, AB, Canada, ³Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, ⁴University of Southern Denmark, Odense, Denmark, ⁵Radiology & Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, ⁶Rheumatology, St. Vincent's Hospital, Melbourne, Australia, ⁷Medicine, Medicine, University of Alberta, Edmonton, AB, Canada, ⁸Department of Radiology and Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, ⁹CaRE Arthritis, Edmonton, Canada, Edmonton, AB, Canada, ¹⁰CaRE Arthritis, Edmonton, AB, Canada
Background/Purpose: Bone marrow lesion (BML) in hip osteoarthritis (OA) may be a determinant of prognosis and a target for emerging anti-inflammatory therapies. We developed the…
Abstract Number: 3133 • 2016 ACR/ARHP Annual Meeting
Association Between Quantitatively Measured Infrapatellar Fat Pad High Signal Intensity Alteration and Knee Structural and Symptomatic Abnormalities in Patients with Symptomatic Knee Osteoarthritis
WEIYU HAN¹, Graeme Jones² and Changhai Ding², ¹Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia, ²Musculoskeletal Unit, Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia
Background/Purpose: Infrapatellar fat pad (IPFP), a local adipose tissue, may have important contributions to knee osteoarthritis (OA). IPFP signal intensity alterations on MRI may represent…
Abstract Number: 1299 • 2015 ACR/ARHP Annual Meeting
Can Bone Marrow Lesions be Scored More Reliably and Responsively in Knee Osteoarthritis Using a Web-Based Overlay System (KIMRISS) Than By Standard MRI Osteoarthritis Knee Scoring (MOAKS)? Data from the Osteoarthritis Initiative and a Prospective Trial of Adaluminab Therapy
Jacob Jaremko¹, Mark Buller², Dean Jeffery², David McDougall³, Benjamin Smith², Robert G Lambert¹ and Walter Maksymowych⁴, ¹Radiology, Radiology, University of Alberta, Edmonton, AB, Canada, ²Radiology & Diagnostic Imaging, University of Alberta, Edmonton, AB, Canada, ³Radiology, University of Alberta, Edmonton, AB, Canada, ⁴Medicine, University of Alberta, Edmonton, AB, Canada
Background/Purpose: Bone marrow lesions (BML) relate to pain and prognosis in knee osteoarthritis. The Knee Inflammation MRI Scoring System (KIMRISS) offers simple template-assisted binary BML…
Abstract Number: 1821 • 2014 ACR/ARHP Annual Meeting
The Co-Occurrence Patterns of MRI Lesions and Incident Knee Osteoarthritis: The MOST Study
Jingbo Niu¹, David T. Felson², Tuhina Neogi³, Michael C. Nevitt⁴, Cora E. Lewis⁵, James Torner⁶, Ali Guermazi⁷, Frank Roemer⁸ and Yuqing Zhang³, ¹Clinical Epidemiology Research and Training Unit, Boston University, Boston, MA, ²Clinical Epidemiology Research & Training Unit, Boston University School of Medicine, Boston, MA, ³Boston University School of Medicine, Boston, MA, ⁴Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, ⁵Preventive Medicine, University of Alabama, Birmingham, Birmingham, AL, ⁶Epidemiology, University of Iowa, Iowa City, IA, ⁷Radiology, Boston University School of Medicine, Boston, MA, ⁸Klinikum Augsburg, Augsburg, Germany
Background/Purpose: MRI imaging provides insights of tissue-specific lesions of osteoarthritis (OA) and has the advantage of identifying earlier pathological changes that are not evident on…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].